Tumors evolve rapidly in a childhood cancer, leaving fewer obvious treatment targets

An extensive genomic study of the childhood cancer neuroblastoma reinforces the challenges in treating the most aggressive forms of this disease. Unexpectedly, the scientists found relatively few recurrent gene mutations.